Men's immune response to brain protein may explain their higher rates of Parkinson's disease
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.
La Jolla News Nuggets: Home project appeal; restaurant site work; sinkhole repaired; more
“The lower the amount of an antibody you can deliver to someone, the easier it will be to manufacture a treatment, and the ...
Science Daily5d
Stopping asthma in its tracks
New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.
News Medical on MSN22h
As dengue spreads, researchers discover a clue to fighting the virus
Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a new study ...
News Medical on MSN6d
New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma, other inflammatory diseases
Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma ...
New Ebola virus research boosts pandemic preparedness
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...
technologynetworks5d
Developing Long-Lasting Relief for Asthma Patients
Two therapeutic "cocktails" could stop immune cells from overreacting to allergens, providing long-lasting asthma relief.
News Medical on MSN3d
New human antibody shows promise for Ebola virus treatment
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...